Literature DB >> 18826842

Recent shift in age pattern of dengue hemorrhagic fever, Brazil.

Maria Gloria Teixeira, Maria Conceição N Costa, Giovanini Coelho, Mauricio L Barreto.   

Abstract

Entities:  

Mesh:

Year:  2008        PMID: 18826842      PMCID: PMC2609867          DOI: 10.3201/eid1410.071164

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Brazil is responsible for >60% of reported cases of dengue fever (DF) in the American region (a designation of the Pan American Health Organization, which includes all of North, Central and South America) (). The epidemiologic characteristics of dengue diseases in Brazil differ from those described in Southeast Asia. In Brazil, the incidence of DF and dengue hemorrhagic fever (DHF) is highest in adults. By contrast, in Southeast Asia, DHF cases predominate and occur more often in children than in adults (,). We describe a preliminary report of a shift in age group predominance that was observed during the 2007 countrywide dengue epidemic in Brazil. The Hospital Information System is the source of data describing the distribution of DHF cases from January 1998 through December 2007 (). In Brazil almost all patients with a diagnosis of DHF are hospitalized. This country has promulgated the use of the World Health Organization’s DHF case definitions (International Classification of Diseases, 10th revision – A91). In the 2007 epidemic, a larger than normal proportion of cases were DHF (2,706), more than twice the largest number of such cases reported in previous years. Moreover, in 2007 >53% of cases were in children <15 years of age; during 1998–2006, the predominance of DHF cases were in the 20- to 40-year age group (Appendix Figure). During 1998–2006, the percentage of DHF cases in children varied from 9.5% (in 1998) to 22.6% (in 2001). Of the 2,706 DHF cases in 2007, 1,710 (63.2%) were reported from the northeast region; 1,119 (65.4%) of these were in children <15 years of age. The southeast region had the next largest number (558), accounting for 20.6% of all reported cases; however, only 26.2% were in children. Other regions with cases, central-west and northern, reported no substantial change in age distribution compared with earlier years. Among the 9 states in northeastern Brazil, DHF predominance in children was observed in Maranhao (609 cases; 92.0% in children), Rio Grande do Norte (97 cases and 77.6%), Pernambuco (316 cases and 67.0%), and Ceara (197 cases and 48.0%). The change in age distribution of cases in 2007 is unique in the modern history of dengue in Brazil and requires an explanation. Dengue 1 and 2 viruses, which were introduced in the 1990s, generated epidemics of DF characterized by a low incidence of DHF, predominantly in adults. With the introduction of dengue 3 virus in 2000–2001, DF epidemics of greater magnitude were observed, with a slightly larger fraction of DHF cases. Differences in the epidemiologic patterns in Southeast Asia and the American region have been attributed to genetic resistance in black populations and to underreporting of DHF cases, among other factors (). These factors seem insufficient to explain the sudden change observed; should it persist—as it has in Venezuela, Colombia, Central America, and Cuba—this change may bring dengue in Brazil to a pattern closer to that of Southeast Asia (). This change in epidemiologic pattern of dengue cases supports calls for improvement in design of dengue surveillance studies to include, where possible, population-based serologic studies. These epidemiologic changes also serve as an alert to health authorities in the American region to update their healthcare services to provide agile, opportune, and good quality care for patients, particularly children, with DHF, to reduce deaths.

Appendix Figure

Number of hospitalizations for dengue hemorrhagic fever by age group and year of occurrence, Brazil, 1998-2007.
  2 in total

Review 1.  Dengue and dengue hemorrhagic fever epidemics in Brazil: what research is needed based on trends, surveillance, and control experiences?

Authors:  Maria da Glória Teixeira; Maria da Conceição Nascimento Costa; Maurício Lima Barreto; Eduardo Mota
Journal:  Cad Saude Publica       Date:  2005-09-12       Impact factor: 1.632

Review 2.  Dengue in the Americas and Southeast Asia: do they differ?

Authors:  Scott B Halstead
Journal:  Rev Panam Salud Publica       Date:  2006-12
  2 in total
  46 in total

1.  Quality of life among adults with confirmed dengue in Brazil.

Authors:  Celina Maria Turchi Martelli; Nazareth Elias Nascimento; Jose A Suaya; Joao Bosco Siqueira; Wayner Vieira Souza; Marilia Dalva Turchi; Adriana Oliveira Guilarde; Joao Borges Peres; Donald S Shepard
Journal:  Am J Trop Med Hyg       Date:  2011-10       Impact factor: 2.345

2.  Postmortem Diagnosis of Dengue as an Epidemiological Surveillance Tool.

Authors:  Luciano Pamplona de Góes Cavalcanti; Deborah Nunes de Melo Braga; Lívia Maria Alexandre da Silva; Marina Gondim Aguiar; Mariana Castiglioni; José Udevanier Silva-Junior; Fernanda Montenegro de Carvalho Araújo; Renata Allana da Costa Pereira; Danielle Lima Malta; Margarida Maria de Lima Pompeu
Journal:  Am J Trop Med Hyg       Date:  2015-11-23       Impact factor: 2.345

Review 3.  Emergence of the severe syndrome and mortality associated with dengue and dengue-like illness: historical records (1890 to 1950) and their compatibility with current hypotheses on the shift of disease manifestation.

Authors:  Goro Kuno
Journal:  Clin Microbiol Rev       Date:  2009-04       Impact factor: 26.132

4.  The epidemiology of dengue in the americas over the last three decades: a worrisome reality.

Authors:  José Luis San Martín; Olivia Brathwaite; Betzana Zambrano; José Orlando Solórzano; Alain Bouckenooghe; Gustavo H Dayan; María G Guzmán
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

5.  Clinical Management of Patients with Dengue Infection in Japan: Results from National Database of Health Insurance Claims.

Authors:  Yusuke Kajimoto; Tsutomu Kitajima
Journal:  Am J Trop Med Hyg       Date:  2020-01       Impact factor: 2.345

6.  Geographical gradient of mean age of dengue haemorrhagic fever patients in northern Thailand.

Authors:  Y Nagao; A Tawatsin; S Thammapalo; U Thavara
Journal:  Epidemiol Infect       Date:  2011-05-09       Impact factor: 2.451

Review 7.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

8.  Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study.

Authors:  Maria Aparecida A Figueiredo; Laura C Rodrigues; Maurício L Barreto; José Wellington O Lima; Maria C N Costa; Vanessa Morato; Ronald Blanton; Pedro F C Vasconcelos; Márcio R T Nunes; Maria Glória Teixeira
Journal:  PLoS Negl Trop Dis       Date:  2010-06-01

9.  Testing and validation of high density resequencing microarray for broad range biothreat agents detection.

Authors:  Tomasz A Leski; Baochuan Lin; Anthony P Malanoski; Zheng Wang; Nina C Long; Carolyn E Meador; Brian Barrows; Sofi Ibrahim; Justin P Hardick; Mohamed Aitichou; Joel M Schnur; Clark Tibbetts; David A Stenger
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

10.  Spatial evaluation and modeling of Dengue seroprevalence and vector density in Rio de Janeiro, Brazil.

Authors:  Nildimar Alves Honório; Rita Maria Ribeiro Nogueira; Cláudia Torres Codeço; Marilia Sá Carvalho; Oswaldo Gonçalves Cruz; Mônica de Avelar Figueiredo Mafra Magalhães; Josélio Maria Galvão de Araújo; Eliane Saraiva Machado de Araújo; Marcelo Quintela Gomes; Luciane Silva Pinheiro; Célio da Silva Pinel; Ricardo Lourenço-de-Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.